| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
-Subunits of G11 and Gq in Thyroid Neoplasia1
Division of Endocrinology and Metabolism (M.D.R., W.F.S., M.A.L.) and Division of Endocrine and Oncologic Surgery (M.S., D.S., M.A.Z.), The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
Address all correspondence and requests for reprints to: Michael A. Levine, M.D., Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Room 863, Ross Research Building, 720 Rutland Avenue, Baltimore, Maryland 21205. E-mail: mlevine{at}welchlink.welch.jhu.edu
Activating mutations of the TSH receptor and
-subunit of
Gs (G
s) that increase adenylyl cyclase
activity have been identified in a subset of hyperfunctioning benign
thyroid follicular adenomas and, less commonly, in hypofunctioning
adenomas and carcinomas. In addition, some thyroid tumors exhibit
inappropriate activation of phospholipase C (PLC), a signaling pathway
that has been implicated in the growth and dedifferentiation of thyroid
cells. We therefore hypothesized that some thyroid tumors might be
caused by somatic mutations in the genes encoding the
-chain of
Gq or G11 that result in constitutive
activation of the PLC pathway. We amplified regions of the
q and
11 genes that encode amino acids,
Q209 and R183, and we screened the DNA for mutations by sequence
analysis and denaturing gradient gel electrophoresis. No mutations were
identified after analysis of DNA from 38 thyroid tumors and 2 poorly
differentiated thyroid carcinoma cell lines, including: 13 follicular
adenomas, 10 follicular carcinomas, 5 papillary carcinomas, and 10
hyperplastic nodules from multinodular goiters. We conclude that
activating mutations of
q and
11 are
absent or rare in hypofunctioning thyroid neoplasms and that other
mechanisms must explain the elevated PLC activity reported in thyroid
carcinoma.
This article has been cited by other articles:
![]() |
K. Krohn, D. Fuhrer, Y. Bayer, M. Eszlinger, V. Brauer, S. Neumann, and R. Paschke Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter Endocr. Rev., June 1, 2005; 26(4): 504 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eszlinger, K. Krohn, K. Berger, J. Lauter, S. Kropf, M. Beck, D. Fuhrer, and R. Paschke Gene Expression Analysis Reveals Evidence for Increased Expression of Cell Cycle-Associated Genes and Gq-Protein-Protein Kinase C Signaling in Cold Thyroid Nodules J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1163 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Collins, N. J. Sarlis, M. J. Merino, J. Monroe, S. E. Crawford, J. A. Krakoff, L. C. Guthrie, S. Bonat, P. G. Robey, and A. Shenker Thyroid Carcinoma in the McCune-Albright Syndrome: Contributory Role of Activating Gs{alpha} Mutations J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4413 - 4417. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |